BioXcel Therapeutics (BTAIQ) FCF Margin (2022 - 2026)
BioXcel Therapeutics' FCF Margin came in at -3350.55% for Q2 2026, up 7128.62 percentage points from -10479.17% a year earlier and up 2381.97 percentage points from the prior quarter.
BioXcel Therapeutics (BTAIQ) FCF Margin (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BioXcel Therapeutics reported FCF Margin of -6860.38%, down 435.84 percentage points year-over-year; for FY2025, it came in at -8974.30%, down 5795.70 percentage points from FY2024.
- FCF Margin carries a three-year change of +27153.70 percentage points (FY2022 to FY2025).
- Going back by year, FCF Margin was -3178.60% in FY2024 (+8055.17 pp), -11233.77% in FY2023 (+24894.23 pp) and -36128.00% in FY2022.
- The Q2 2026 figure represents the highest quarterly FCF Margin since Q2 2024.
- Year-over-year, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of -1312.10 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q1 2024 (a gain of 22371.81 percentage points), and the weakest in Q3 2025 (a drop of 11535.83 percentage points).
- Business Quant data shows BTAIQ's FCF Margin at -5732.52% (Q1 2026), -5550.78% (Q4 2025) and -19170.41% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | -3,350.55% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,350.55% |
| Mar 31, 2026 | -5,732.52% |
| Dec 31, 2025 | -5,550.78% |
| Sep 30, 2025 | -19,170.41% |
| Jun 30, 2025 | -10,479.17% |
| Mar 31, 2025 | -7,168.45% |
| Dec 31, 2024 | -4,046.17% |
| Sep 30, 2024 | -7,634.58% |
| Jun 30, 2024 | -2,099.09% |
| Mar 31, 2024 | -3,042.27% |
| Dec 31, 2023 | -7,144.41% |
| Sep 30, 2023 | -11,021.70% |
| Jun 30, 2023 | -8,360.18% |
| Mar 31, 2023 | -25,414.08% |
| Dec 31, 2022 | -16,234.87% |
| Sep 30, 2022 | -22,763.50% |
BioXcel Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();